SYNPO2L | Synaptopodin 2-like | Cytoskeleton related proteins Plasma proteins
| | | | | Group enriched |
TNNI3K | TNNI3 interacting kinase | Enzymes
| | | | | Tissue enriched |
XIRP2 | Xin actin-binding repeat containing 2 | Cancer-related genes Plasma proteins
| | | | | Group enriched |
CSRP3 | Cysteine and glycine-rich protein 3 (cardiac LIM protein) | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
DUSP27 | Dual specificity phosphatase 27 (putative) | | | | | | Group enriched |
HFE2 | Hemochromatosis type 2 (juvenile) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
LMAN1L | Lectin, mannose-binding, 1 like | Predicted membrane proteins
| | | | | Group enriched |
PRSS42 | Protease, serine, 42 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
TRDN | Triadin | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
APOBEC2 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 | | | | | | Group enriched |
CCDC141 | Coiled-coil domain containing 141 | Predicted membrane proteins
| | | | | Tissue enriched |
CHRNE | Cholinergic receptor, nicotinic, epsilon (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
LDB3 | LIM domain binding 3 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
MYOM1 | Myomesin 1 | | | | | | Group enriched |
MYOM2 | Myomesin 2 | | | | | | Group enriched |
PPP1R3A | Protein phosphatase 1, regulatory subunit 3A | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | | | | | | Group enriched |
XIRP1 | Xin actin-binding repeat containing 1 | | | | | | Group enriched |
ANKRD2 | Ankyrin repeat domain 2 (stretch responsive muscle) | | | | | | Group enriched |
ASB18 | Ankyrin repeat and SOCS box containing 18 | Predicted membrane proteins
| | | | | Group enriched |
DAND5 | DAN domain family member 5, BMP antagonist | Predicted secreted proteins
| | | | | Tissue enriched |
GABRB1 | Gamma-aminobutyric acid (GABA) A receptor, beta 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HSPB3 | Heat shock 27kDa protein 3 | Disease related genes
| | | | | Group enriched |
NRAP | Nebulin-related anchoring protein | Plasma proteins
| | | | | Group enriched |
PXDNL | Peroxidasin homolog (Drosophila)-like | Enzymes Predicted secreted proteins
| | | | | Group enriched |
TCAP | Titin-cap | Disease related genes
| | | | | Group enriched |
ACTC1 | Actin, alpha, cardiac muscle 1 | Disease related genes Plasma proteins
| | | | | Tissue enriched |
ASB11 | Ankyrin repeat and SOCS box containing 11 | Predicted membrane proteins
| | | | | Group enriched |
TNNC1 | Troponin C type 1 (slow) | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
PPAPDC3 | Phosphatidic acid phosphatase type 2 domain containing 3 | Predicted membrane proteins
| | | | | Group enriched |
ABRA | Actin-binding Rho activating protein | | | | | | Group enriched |
MB | Myoglobin | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |
MYL3 | Myosin, light chain 3, alkali; ventricular, skeletal, slow | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
MYZAP | Myocardial zonula adherens protein | | | | | | Tissue enriched |
PDE4DIP | Phosphodiesterase 4D interacting protein | Cancer-related genes Disease related genes
| | | | | Group enriched |
PGAM2 | Phosphoglycerate mutase 2 (muscle) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
SBK3 | SH3 domain binding kinase family, member 3 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC25A4 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | Disease related genes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM182 | Transmembrane protein 182 | Predicted membrane proteins
| | | | | Group enriched |
CASQ2 | Calsequestrin 2 (cardiac muscle) | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
FABP3 | Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |
LSMEM2 | Leucine-rich single-pass membrane protein 2 | Predicted membrane proteins
| | | | | Group enriched |
POPDC2 | Popeye domain containing 2 | Predicted membrane proteins
| | | | | Tissue enriched |
RYR2 | Ryanodine receptor 2 (cardiac) | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ALPK3 | Alpha-kinase 3 | Enzymes
| | | | | Group enriched |
CAV3 | Caveolin 3 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CORIN | Corin, serine peptidase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
COX7A1 | Cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
FAM155B | Family with sequence similarity 155, member B | Predicted membrane proteins
| | | | | Group enriched |
HHATL | Hedgehog acyltransferase-like | Predicted membrane proteins
| | | | | Group enriched |